Skip to main content
. 2023 Jun 8;76(8):431–473. doi: 10.1038/s41429-023-00629-8

Fig. 16.

Fig. 16

Antibacterial compounds [natural product (NP), synthetic (S), protein/mammalian peptide (P)] and β-lactamase inhibitors (BLI)] with new antibacterial pharmacophores divided into development phases and their lead derivation source